Skip to main content

Table 3 Associations of VDR SNP genotypes and metabolic and anthropometric measures in response to vitamin D3 supplementation (4000 IU/day) in breast cancer survivors using multivariate multiple regression

From: Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3

Changes in varibles

APa1, β (95% CI)

TaqI, β (95% CI)

BsmI, β (95% CI)

FokI, β (95% CI)

Cdx2, β (95% CI)

Aa

(n = 52)

aa

(n = 18)

Tt

(n = 67)

tt

(n = 14)

Bb

(n = 65)

bb

(n = 16)

Ff

(n = 66)

ff

(n = 17)

GA

(n = 52)

AA

(n = 14)

BMI, Kg/m2

P value

0.13

(−0.17,0,44)

0.39

0.21

(− 0.23, 0.66)

0.35

− 0.06

(− 0.37,.24)

0.66

0.03

(− 0.45,0.53)

0.87

0.08

(− 0.21,0.38)

0.58

0.06

(− 0.41,0.54)

0.78

0.01

(− 0.27,0.31)

0.90

− 0.2

(− 0.6,0.2)

0.37

−0.16

(− 0.46. 0.14)

0.29

0

(− 0.48,0.50)

0.96

WC, cm

P value

−0.4

(−3.3, 2.3)

0.72

0.8

(−3.2,4.8)

0.69

−1.4

(−4.1,1.3)

0.31

− 1.3

(−5.7,3.1)

0.55

2.7

(0.1,5.3)

0.04

3.9

(− 0.2,8.1)

0.06

1.2

(− 1.3,3.9)

0.34

−0.8

(− 4.9,3.2)

0.68

1.8

(− 0.8,4.6)

0.17

−1.2

(− 5.6, 3.2)

0.59

HC, cm

P value

0.9

(− 1.1,3.0)

0.37

0.9

(−2.0,4.0)

0.53

1.9

(− 0.1,3.9)

0.06

0.6

(− 2.6,3.9)

0.70

0.9

(− 1.0,2.9)

0.32

0.1

(− 3.0, 3.3)

0.93

1.4

(− 0.5,3.3)

0.15

0.1

(− 2.9, 3.1)

0.93

−0.8

(− 2.9,1.1)

0.41

0.17

(− 3.1,3.5)

0.91

Fat mass (%)

P value

0.08

(− 0.70,0.86)

0.83

0.53

(− 0.59,1.66)

0.34

−0.1

(− 0.9,0.6)

0.70

−0.2

(− 1.5,0.9)

0.66

0.2

(− 0.5, 1.0)

0.53

0.5

(− 0.6,1.8)

0.3

0.4

(− 0.3,1.1)

0.28

−0.8

(− 2.0,0.3)

0.14

0.06

(− 0.74,0.87)

0.86

−0.2

(− 1.5, 1.1)

0.75

Muscle mass (%)

P value

0.2

(−41.9,42.3)

0.99

71.3

(10.7131.9)

0.02

− 22.0

(− 63.9,19.8)

0.30

− 25.7

(− 93.3,41.8)

0.45

− 22.4

(− 62.1,17.3)

0.26

− 26.7

(− 90.6,37.2)

0.41

19.7

(− 19.9,59.4)

0.32

1.7

(− 59.7,63.2)

0.95

20.3

(− 20.6,61.3)

0.32

− 6.8

(− 73.8,60.1)

0.84

Trunk fat (%)

P value

0. 2

(− 0.8,1.3)

0.67

0.5

(− 1.0,2.1)

0.65

− 0.06

(− 1.15, 1.02)

0.90

−0.1

(− 1.9, 1.5)

0.84

0.3

(− 0.7,1.4)

0.58

0.7

(− 0.9,2.5)

0.38

0.5

(− 0.5,1.6)

0.34

− 1.0

(− 2.7,0.6)

0.22

0.2

(− 0.9,1.3)

0.71

− 0.2

(− 2.1,1.5)

0.77

Visceral fat

P value

0.1

(− 0.2,0.4)

0.5

0.2

(− 0.2,0.7)

0.37

− 0.1

(− 0.4,0.2)

−0.1

(− 0.7,0.3)

− 0.04

(− 0.37,0.27)

0.77

0.3

(− 0.1,0 .8)

0.17

0.1

(− 0.1,0.4)

0.32

−0.2

(− 0.7,0.2)

0.38

−0.03

(− 0.3,0.3)

0.82

−0.04

(− 0.6,0.5)

0.86

LDL, mg/dL

P value

− 4.0

(− 15.0,6.8)

0.46

− 17.9

(− 33.6, − 2.3)

0.02

0.6

(− 10.1,11.3)

0.90

7.4

(− 10.0,24.9)

0.40

3.9

(− 6.3,14.2)

0.44

2.1

(− 14.5,18.8)

0.79

3.2

(− 7.0,13.5)

0.53

−2.5

(− 18.5,13.5)

0.75

−6.5

(− 16.9,3.8)

0.21

− 18.1

(− 35.3, − 0.9)

0.03

HDL, mg/dL

P value

0.9

(− 3.5,5.4)

0.68

2.3

(− 4.0,8.8)

0.46

−2.2

(− 6.5,2.06)

0.30

0.84

(− 6.1,7.8)

0.81

− 1.8

(− 5.9,2.3)

0.38

3.3

(− 3.2,10.0)

0.31

1.4

(−2.6.5.5)

0.48

− 0.6

(− 7.10,5.7)

0.83

− 0.7

(− 5.0, 3.4)

0.72

1.2

(− 5.7, 8.2)

0.72

TC, mg/dL

P value

−4.1

(− 18.9,10.7)

0.58

−4.8

(− 26.0,16.3)

0.65

−9.7

(− 23.9,4.4)

0.17

3.7

(− 19.3,26.7)

0.75

3.8

(− 10.1,17.9)

0.58

11.4

(− 11.3,34.2)

0.32

−1.2

(− 15.3,12.7)

0.85

−3.8

(− 25.7,18.0)

0.72

−9.8

(− 24.1, 4.4)

0.17

−22.1

(− 45.7, 1.3)

0.06

TG, mg/dL

P value

6.3

(− 14.1,26.8)

0.54

− 13.1

(− 42.4,16.2)

0.37

2.5

(− 17.3,22.4)

0.79

21.2

(− 11.0,53.6)

0.19

8.6

(− 10.4, 27.7)

0.37

−4.5

(− 35.4, 26.3)

0.77

−9.4

(− 28.4,9.5)

0.32

6.2

(− 23.3,35.8)

0.67

− 3.0

(− 22.6,16.4)

0.75

−25.9

(− 58.1, 6.2)

0.11

  1. BMI Body mass index, WC Waist circumference, HC Hip circumference, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, TG Triglycerides
  2. All values were adjusted for age, baseline 25-hydroxy vitamin D (25(OH)D), energy intake, fat intake and physical activity